Dr Mary Panjari BSc GradDipEd GradDip Women's Health MWH PhD is a postdoctoral fellow with an interest in women’s health. She completed a Masters of Women's Health at the University of Melbourne where her research project investigated women who spontaneously quit smoking during pregnancy. For this work, she was awarded a Young Investigators Award, Perinatal Society of Australia and New Zealand, 1st Annual Congress, 1997 and Victorian Public Health Award for Excellence and Innovation (Commended) in 1999. Dr Panjari continued working in women's health research before moving to opiate addiction research at Turning Point Drug and Alcohol Centre. She completed her PhD at Monash University in 2009. Her project was a study of the efficacy of oral DHEA therapy for improved sexual function and wellbeing in postmenopausal women. She presented this work at the NAMS conference 2008 where her abstract was one of the top 3. In 2011 Dr Panjari was awarded an NH&MRC Early Career Fellowship to reseach the impact of treatment for bowel cancer on womens health.
Panjari, M., Bell, R.J., Burney, S., Bell, S.W., McMurrick, P., Davis, S.R., 2012, Sexual function, incontinence, and wellbeing in women after rectal cancer-a review of the evidence, Journal Of Sexual Medicine [P], vol 9, issue 11, Wiley-Blackwell Publishing Ltd., United Kingdom, pp. 2749-2758.
Panjari, M., Davis, S., Fradkin, P., Bell, R., 2011, Breast cancer survivors' beliefs about the causes of breast cancer, Psycho-Oncology [E], vol E, John Wiley & Sons Ltd, United Kingdom, pp. 1-6.
Panjari, M., Bell, R., Fradkin, P., Davis, S., 2011, Cosmetic surgery prior to diagnosis of breast cancer, Climacteric [P], vol E, Informa Healthcare, United Kingdom, pp. 1-5.
Davis, S., Panjari, M., Stanczyk, F., 2011, DHEA replacement for postmenopausal women, Journal of Clinical Endocrinology and Metabolism [P], vol 96, issue 6, The Endocrine Society, United States, pp. 1642-1653.
Panjari, M., Bell, R., Davis, S., 2011, Sexual Function after Breast Cancer, Journal Of Sexual Medicine [P], vol 8, issue 1, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 294-302.
Panjari, M., Davis, S., 2011, Vaginal DHEA to treat menopause related atrophy: A review of the evidence, Maturitas [P], vol 70, issue 1, Elsevier Ireland Ltd, Ireland, pp. 22-25.
Panjari, M., Davis, S., 2010, DHEA for postmenopausal women: A review of the evidence, Maturitas [P], vol 66, issue 2, Elsevier Ireland Ltd, Ireland, pp. 172-179.
Panjari, M., Bell, R., Lijovic, M., La China, M., Schwarz, M., Fradkin, P., Bradbury, J., Farrugia, H., Davis, S., 2010, The relationship between hormone therapy use at the time of diagnosis of breast cancer and tumor characteristics, Hormones and Cancer [P], vol E, issue 2, Springer New York LLC, United States, pp. 93-99.
Panjari, M., Bell, R.J., Jane, F.M., Wolfe, R.S.J., Adams, J., Morrow, C., Davis, S.R., 2009, A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido, Journal of Sexual Medicine [E], vol 6, issue 9, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 2579-2590.
Panjari, M., Bell, R.J., Jane, F.M., Adams, J., Morrow, C., Davis, S.R., 2009, The safety of 52 weeks of oral DHEA therapy for postmenopausal women, Maturitas [P], vol 63, issue 3, Elsevier Ireland Ltd, Ireland, pp. 240-245.
Panjari, M., Bell, R.J., Adams, J., Morrow, C., Papalia, M., Astbury, J., Davis, S.R., 2008, Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women, Journal of Women's Health, vol 17, issue 10, Mary Ann Liebert, Inc, USA, pp. 1559-1565.
Panjari, M., Davis, S.R., 2007, DHEA therapy for women: effect on sexual function and wellbeing, Human Reproduction Update, vol 13, issue 3, Oxford University Press, UK, pp. 239-248.
Digiusto, E., Panjari, M., Gibson, A., Rea, F., 2006, Follow-up difficulty: Correlates and relationship with outcome in heroin dependence treatment in the NEPOD study, Addictive Behaviors [P], vol 31, issue 7, Pergamon, United Kingdom, pp. 1201-1210.
Lintzeris, N., Ritter, A.J., Panjari, M., Clark, N., Kutin, J.J., Bammer, G., 2004, Implementing buprenorphine treatment in community settings in Australia: experiences from the buprenorphine implementation trial, The American Journal on Addictions, vol 13, Taylor & Francis Inc., USA, pp. 29-41.
Ritter, A.J., Lintzeris, N., Kutin, J.J., Bammer, G., Panjari, M., 2003, A randomized trail comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia, Addiction [P], vol 98, Wiley-Blackwell Publishing Ltd., United Kingdom, pp. 1605-1613.
Ritter, A.J., Lintzeris, N., Clark, N., Kutin, J.J., Bammer, G., Panjari, M., 2003, A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia, Addiction, vol 98, Blackwell Publishing Ltd, UK, pp. 1605-1613.
Muhleisen, P., Panjari, M., Lee, N.K., 2003, Buprenorphine dispensing in a cohort of community pharmacies in Victoria, Australian Pharmacist, vol 22, issue 3, Pharmaceutical Society of Australia, Australia, pp. 229-234.
Authorised by: Director, Office of Marketing and Communications.
Maintained by: eSolutions ServiceDesk.
Last updated: 18 February 2013.
Copyright © 2013 Monash University. ABN 12 377 614 012 -
Accessibility -
Caution -
Privacy
CRICOS Provider Number: 00008C
We acknowledge and pay respects to the Elders and Traditional Owners of the land on which our six Australian campuses stand. Information for Indigenous Australians
